Food Safety Act 1990 Summary

However, among the other resistances, the financial crisis has led to a decrease in funds available for biotechnology companies. This update fully CRO Market Outlook assesses market drivers and resistors and predicts the effects of these. The report analyzes the major trends in the industry, examines the areas that are set to see growth in the CRO business; leading CRO evaluates, and describes the future of the industry. The report provides an overview of conditions in seven emerging regions including China, India and Latin America. It highlights the evolution of business models and relationships between corporate sponsors and CROs and allows optimal outsourcing strategy.

The main features of this report

Identifies and analyzes the latest trends and problems of outsourcing R & D Clinical

Describes where clinical trials will be conducted in the future

Explores the complexities and costs of outsourcing R & D in different regions of the world

Profiles of leading international CRO

Provides a detailed assessment of the current market, including information CRO market share and size / growth of R & D

Focusing on emerging markets CRO

Highlights of the evolution of strategies for working with CRO

Examines current and future business models CRO

The main conclusions of this report

The total CRO market is estimated at 20 billion dollars in 2008 and should grow at an annual rate of 8.5% to $ 35 billion through 2015. The market is very fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.

CROs provide substantial global capacity to drug developers and have become key factors in the business of clinical trials. Projects involving high CRO are associated with shorter development time.

Among the large global contract research organization, Quintiles is market leader, with 15% of global market share, followed by Covance and PPD. The five largest CROs have increased their market share and now hold 55% of the total market.

The ROC's leading provider of commodities are a full service operating worldwide. They act as one-stop shops for all services, from preclinical through marketing.

The number of clinical studies conducted in Asia, Central and Eastern Europe and Latin America is growing steadily. India and China are the future outsourcing destinations of choice.

CROs and pharmaceutical companies are turning to strategic partnerships to gain a competitive advantage in the global trading environment.


Contents:
Summary
The market for contract research organization worldwide
CRO market analysis
areas established on the world market CRO
emerging regions in the world market CRO
Key players in the global CRO market
The future of contract research
Chapter 1 The market for contract research organization worldwide
Summary
Introduction
The contribution to drug development CRO
Market Overview
Key market drivers
Key market restrictions
Conclusions and Key Findings
Overview of the global CRO market
Total estimated revenue
Global spending on R & D and CRO market size
Global clinical outsourcing
The contribution of CRO to drug development
Current market drivers
The growth of R & D in biotechnology and pharmaceutical
Cost pressures encourage R & D outsourcing
Long term growth and spending on research and biotechnology companies
Growing regulatory burden and security concerns
U.S.
EU
Patient recruitment
Increase the number of products under development
The development of biomarkers
limitations of the current market
Near-term reductions in biotechnology R & D spending.